Rice facility is ‘one-stop shop’ for customizing DNA to fight cancer
Rice bioengineers, synthetic biologists and cancer researchers celebrated the opening of Rice’s first CPRIT Core Facility, the Genetic Design and Engineering Center, or GDEC, Nov. 10 at the BRC.
Bacterial sensors send a jolt of electricity when triggered
Rice researchers develop programmable bacteria that sense contaminants and release an electronic signal in real time.
Even good gene edits can go bad
A Rice lab leads the effort to reveal threats to the efficacy of gene editing, even when it appears to be working.
RNA-editing tool a fast, sensitive test for COVID-19
Researchers at Rice University and the University of Connecticut modify a gene editing tool to serve as a highly sensitive diagnostic test for the presence of the SARS-CoV-2 virus.
Rice lab grows macroscale, modular materials from bacteria
Rice bioscientists have created bacteria that self-assembles into a material like putty that could soak up pollutants.
Bird’s enzyme points toward novel therapies
Rice University chemists find a rare genetic pathway that helps mammalian cells become drug factories or sensors by synthesizing noncanonical amino acids. The clues came from an uncommon bird.
‘Drug factory’ implants eliminate mesothelioma tumors in mice
Rice and Baylor researchers have used Rice’s “drug factory” implants to eradicate advanced-stage mesothelioma tumors in mice.
Rice models moving ‘washers’ that help DNA replicate
Rice researchers model a key mechanism by which DNA replicates. The study could help identify new targets to treat disease.
Rice, Baylor developing implants to heal heart attack injuries
Rice and Baylor College of Medicine are creating tiny implants that can heal damage from heart attacks.
Rice lab’s ‘drug factory’ implants cleared for human trials
Federal regulators have approved the first human clinical trial of cancer-killing “drug factory” implants created by Rice bioengineers.
Synthetic tools conduct messages from station to station in DNA
Bioengineers used deactivated Cas9 fusion proteins to synthetically control gene expression and reveal new details about natural processes in human cells.
SARS-Arena reveals hidden hooks in virus
SARS-Arena will help to find conserved parts in proteins from SARS-CoV-2 that could be a key for the development of wide-spectrum vaccines.
Researchers discover new leukemia-killing compounds
Researchers from Rice and MD Anderson Cancer Center have discovered potential new drugs for treating leukemia.
Process to customize molecules does double duty
Chemists develop a method to add two fragments to an alkene molecule in a single process, which could simplify drug and materials design.
CPRIT grants entice three cancer researchers to Rice
Rice University recruits three professors to bolster cancer research with grants from the Cancer Prevention and Research Institute of Texas.
